✦ LIBER ✦

DTaP vaccine added to UK preschool immunisation schedule

Book ID: 120864006
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 151 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200113140-00009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DTaP and MMR vaccine schedule to resume

DTaP and MMR vaccine schedule to resume in the US

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 149 KB

The cost-effectiveness of introducing a

The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule

✍ P Scuffham; N Devlin; J Eberhart-Phillips; R Wilson-Salt 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Budget Impact Analisis of Switching from

Budget Impact Analisis of Switching from DPT and Monovalent Vaccines to DTaP–IPV-Hib Combined Vaccine into Russian Immunization Schedule

✍ Kulikov, A.; Akimova, Y.I. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Immunogenicity and safety of influenza v

Immunogenicity and safety of influenza vaccination in 3- to 6-year-old children with a two dose immunisation schedule

✍ C. Van Hoecke; W. Raue; W. Künzel; H. Engelmann 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 545 KB

Evaluation of the response to an acceler

Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals

✍ JM Minke; CM El-Hage; P Tazawa; D Homer; L Lemaitre; V Cozette; JR Gilkerson; PD 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

105Ad7 cancer vaccine stimulates anti-tu

105Ad7 cancer vaccine stimulates anti-tumour helper and cytotoxic T-cell responses in colorectal cancer patients but repeated immunisations are required to maintain these responses

✍ Lindy G. Durrant; Declan J. Buckley; R. Adrian Robins; Ian Spendlove 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB

105AD7 is a human anti-idiotypic antibody that recognises the binding site of the anti-tumour antibody 791T/36 and can thereby mimic the CD55 antigen. The molecular basis of 105AD7 mimicry has been identified with 3 CDR regions of 105AD7 showing similarity to 3 regions of CD55. These regions have be